The manufactures doses will only be produced by the manufacturer and may be in shortage, but compounded custom doses may continue even after the regulatory changes
Talk to your healthcare provider about low blood sugar levels and how to manage them
Read the press release: #publichealth #drugawareness #harmreduction To view or add a comment, sign in A judge just gave the green light to Eli Lillys lawsuit over claims that a compounder marketed copycat versions of its obesity drugs as personalized. Cases like this show why healthcare businesses need to be extra careful with how treatments are promoted and described
Who Might Benefit Most From Each Medication
Similarly, the study could not find any association between changes in circulating GLP-1 and changes in IBS symptom severity, highlighting the need for identifying underlying mechanisms driving these changes
Longer-term safety data including effects on thyroid function, pancreatitis risk, and cardiovascular outcomes are still being gathered through ongoing Phase 3 trials